Clinical Trial Update: Tigecycline for Treatment of Rapidly Growing Mycobacteria [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tigecycline for rapidly growing mycobacterial lung disease, including Mycobacterium abscessus, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Lung Disease
• Rapidly Growing Mycobacterial Lung Disease

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

Sponsor: The University of Texas Health Science Center at Tyler | Conditions: Mycobacterium Abscessus Lung Disease, Rapidly Growing Mycobacterial Lung Disease | Phase 2 | Status: COMPLETED